Treatment of Sleep Maintenance Insomnia

First-Line Treatment

The American Academy of Sleep Medicine recommends Cognitive Behavioral Therapy for Insomnia (CBT-I) as the standard treatment for chronic insomnia, including sleep maintenance problems 1, 2, 3
CBT-I is a multicomponent approach that combines cognitive therapy with behavioral interventions and educational components, including stimulus control, sleep restriction therapy, cognitive therapy, relaxation techniques, and sleep hygiene education 1, 2, 4
Sleep restriction therapy is specifically effective for sleep maintenance problems by enhancing sleep drive and consolidating sleep, and involves limiting time in bed to match actual sleep duration based on sleep logs 1, 2, 5
Stimulus control helps break the association between bed and wakefulness, and involves instructions such as going to bed only when sleepy, getting out of bed when unable to sleep within 20 minutes, and using bed only for sleep and sex 1, 5

If behavioral interventions are unsuccessful after 2-4 weeks, consider pharmacological options, including FDA-approved medications such as eszopiclone and temazepam, as well as low-dose sedating antidepressants like trazodone and doxepin 6, 7, 8, 9
The American Academy of Sleep Medicine and the Annals of Internal Medicine recommend considering pharmacological options only after behavioral interventions have been unsuccessful 6, 7

Implement CBT-I as the foundation of treatment, and document sleep patterns using sleep logs 1, 6, 2, 3
Focus on stimulus control and sleep restriction therapy, and consider adding relaxation techniques or biofeedback if insufficient improvement is seen after 4 weeks 1, 2, 5
Evaluate for other contributing factors, such as medical conditions or medications, and consider short-term pharmacological therapy if still insufficient after 6-8 weeks 6, 7, 8, 9

Regular reassessment of sleep patterns is essential to evaluate treatment efficacy, and beware of medication side effects such as residual daytime sedation and complex sleep behaviors 9, 10
Sleep maintenance difficulties are more common than isolated sleep-onset difficulties, especially in older adults, and the American Academy of Sleep Medicine recommends avoiding long-term use of benzodiazepines due to risk of dependence, tolerance, and cognitive impairment 6, 4, 8

The American Geriatrics Society recommends sleep hygiene education, including avoiding caffeine after noon, limiting alcohol, and keeping the bedroom dark and cool, as part of cognitive behavioral therapy for insomnia (CBT-I) 11, 12

The American Geriatrics Society suggests that patients with sleep maintenance insomnia should avoid antihistamines, such as diphenhydramine and doxylamine, due to anticholinergic effects, daytime sedation, and risk of delirium in older patients 13, 14
The American Geriatrics Society recommends that patients with sleep maintenance insomnia should avoid antipsychotics as first-line treatment due to metabolic side effects 13, 14

The American Geriatrics Society recommends attempting medication tapering after 4-8 weeks when sleep consolidates, and ongoing monitoring for patients requiring long-term medication 13, 14

The American Geriatrics Society advises against prescribing sleep medications without concurrent behavioral therapy, as this can lead to dependence without addressing underlying sleep architecture problems 13, 14
The American Geriatrics Society recommends screening for underlying causes of insomnia, such as sleep apnea, restless legs syndrome, medication side effects, pain, nocturia, or psychiatric conditions, before assuming primary insomnia 11, 12

The American College of Physicians establishes a clear treatment algorithm that does not include herbal remedies like lemon balm as recommended interventions 15, 16, 17, 18
CBT-I should be the initial treatment for all adults with chronic insomnia disorder, including those with sleep onset difficulties 15
Moderate-quality evidence demonstrates that CBT-I improves sleep onset latency, sleep efficiency, and sleep quality in the general population 16, 17, 18
The American College of Physicians recommends using shared decision-making to consider FDA-approved medications if CBT-I fails after 4-8 weeks 15, 16, 17, 18
Zolpidem has moderate-quality evidence for improving sleep onset latency and total sleep time 16, 17, 18
Eszopiclone has low-to-moderate quality evidence for improving sleep onset latency 16, 17, 18
Suvorexant has moderate-quality evidence for improving sleep onset latency 16, 17, 18

Do not recommend herbal remedies as alternatives to evidence-based treatments, as this delays effective intervention and may worsen chronic insomnia 15
Consider FDA-approved pharmacotherapy only if CBT-I fails, using shared decision-making to discuss benefits, harms, and costs 15, 16